Ergomed

Activities: Regulatory

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Ergomed strongly positioned for future growth in new partnership with Permira

Through this partnership, Permira will support Dr. Miroslav Reljanović and the team in Ergomed’s next phase by accelerating the growth of the business
Research & Development

Ergomed Board and Management changes
Regulatory

Ergomed subsidiary PrimeVigilance enters US market and opens office in Boston, USA

US base gives PrimeVigilance the presence needed to support its current North American clients
Regulatory

Ergomed makes changes to Board of Directors

Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed
Research & Development

Ergomed strengthens management team

Andrew Mackie brings 25 years of industry experience to lead business development at the company
Regulatory

Peter George joins Board of Ergomed as Non-Executive Director

He is currently Chief Executive of Clinigen
Subscribe now